Canagliflozin Completed Phase N/A Trials for Type 2 Diabetes Mellitus

CompletedNot AvailableNot Available IdentifierTitleDrugs
NCT03604224A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
NCT03249506Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)